Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCT of two non-prolonged pituitary down-regulation ovarian stimulation protocols in endometriosis patients undergoing IVF/ICSI
ChiCTR-IPR-15006380Phase 3Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human menopausal gonadotrophin, medroxyprogesterone acetate and gonadotropin-releasing hormone agonist in endometriosis and infertility (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: oocyte retrieval rate, maturation rate and 4 more. Started May 2015; status: recruiting.
02
Drugs
human menopausal gonadotrophinmedroxyprogesterone acetategonadotropin-releasing hormone agonist
03
Conditions
endometriosisinfertility
Beyond the preview
Go deeper on ChiCTR-IPR-15006380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006380.